Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason M Walraven

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 21, 2007
Computational and experimental analyses of mammalian arylamine N-acetyltransferase structure and functionJason M Walraven, John O Trent, David W Hein
Drug Metabolism Reviews|February 9, 2008
Structure-function analyses of single nucleotide polymorphisms in human N-acetyltransferase 1Jason M Walraven, John O Trent, David W Hein
The Journal of Pharmacology and Experimental Therapeutics|July 11, 2006
Identification and characterization of functional rat arylamine N-acetyltransferase 3: comparisons with rat arylamine N-acetyltransferases 1 and 2Jason M Walraven, Mark A Doll, David W Hein
Current Drug Metabolism|August 6, 2008
Structure/function evaluations of single nucleotide polymorphisms in human N-acetyltransferase 2Jason M Walraven, Yu Zang, John O Trent, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 15, 2007
Tissue expression and genomic sequences of rat N-acetyltransferases rNat1, rNat2, rNat3, and Functional characterization of a novel rNat3*2 genetic variantJason M Walraven, David F Barker, Mark A Doll, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 30, 2005
4,4'-methylenedianiline-induced hepatotoxicity is modified by N-acetyltransferase 2 (NAT2) acetylator polymorphism in the ratXiaoyan Zhang, Jason C Lambert, Mark A Doll, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 19, 2008
Quantitative tissue and gene-specific differences and developmental changes in Nat1, Nat2, and Nat3 mRNA expression in the ratDavid F Barker, Jason M Walraven, Elizabeth H Ristagno, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 21, 2007
Computational and experimental analyses of mammalian arylamine N-acetyltransferase structure and functionJason M Walraven, John O Trent, David W Hein
Drug Metabolism Reviews|February 9, 2008
Structure-function analyses of single nucleotide polymorphisms in human N-acetyltransferase 1Jason M Walraven, John O Trent, David W Hein
The Journal of Pharmacology and Experimental Therapeutics|July 11, 2006
Identification and characterization of functional rat arylamine N-acetyltransferase 3: comparisons with rat arylamine N-acetyltransferases 1 and 2Jason M Walraven, Mark A Doll, David W Hein
Current Drug Metabolism|August 6, 2008
Structure/function evaluations of single nucleotide polymorphisms in human N-acetyltransferase 2Jason M Walraven, Yu Zang, John O Trent, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 15, 2007
Tissue expression and genomic sequences of rat N-acetyltransferases rNat1, rNat2, rNat3, and Functional characterization of a novel rNat3*2 genetic variantJason M Walraven, David F Barker, Mark A Doll, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 30, 2005
4,4'-methylenedianiline-induced hepatotoxicity is modified by N-acetyltransferase 2 (NAT2) acetylator polymorphism in the ratXiaoyan Zhang, Jason C Lambert, Mark A Doll, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 19, 2008
Quantitative tissue and gene-specific differences and developmental changes in Nat1, Nat2, and Nat3 mRNA expression in the ratDavid F Barker, Jason M Walraven, Elizabeth H Ristagno, et al.
Pageof 1